Latest & greatest articles for calcium

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on calcium or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on calcium and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for calcium

1. Do Calcium Antagonists Decrease Mortality or Dependency in Acute Ischemic Stroke?

Do Calcium Antagonists Decrease Mortality or Dependency in Acute Ischemic Stroke? Do Calcium Antagonists Decrease Mortality or Dependency in Acute Ischemic Stroke? - Annals of Emergency Medicine Email/Username: Password: Remember me Search Terms Search within Search Share this page Access provided by Volume 74, Issue 4, Pages 575–577 Do Calcium Antagonists Decrease Mortality or Dependency in Acute Ischemic Stroke? x Rachel E. Bridwell , MD (EBEM Commentator) , x Brit Long , MD (EBEM Commentator (...) ) , x Michael D. April , MD, DPhil (EBEM Commentator) Department of Emergency Medicine, San Antonio Uniformed Services Health Education Consortium, Fort Sam Houston, TX DOI: | Publication History Published online: May 09, 2019 Expand all Collapse all Article Outline Take-Home Message The use of calcium antagonists in acute ischemic stroke does not reduce mortality or dependency in activities of daily living. Methods Data Sources An information specialist searched the Cochrane Stroke Group Trials

2019 Annals of Emergency Medicine Systematic Review Snapshots

2. Calcium supplementation commencing before or early in pregnancy, for preventing hypertensive disorders of pregnancy. (PubMed)

Calcium supplementation commencing before or early in pregnancy, for preventing hypertensive disorders of pregnancy. The hypertensive disorders of pregnancy include pre-eclampsia, gestational hypertension, chronic hypertension, and undefined hypertension. Pre-eclampsia is considerably more prevalent in low-income than in high-income countries. One possible explanation for this discrepancy is dietary differences, particularly calcium deficiency. Calcium supplementation in the second half (...) of pregnancy reduces the serious consequences of pre-eclampsia, but has limited effect on the overall risk of pre-eclampsia. It is important to establish whether calcium supplementation before, and in early pregnancy (before 20 weeks' gestation) has added benefit. Such evidence could count towards justification of population-level interventions to improve dietary calcium intake, including fortification of staple foods with calcium, especially in contexts where dietary calcium intake is known

2019 Cochrane

3. Genetic predisposition to increased serum calcium, bone mineral density, and fracture risk in individuals with normal calcium levels: mendelian randomisation study. (PubMed)

Genetic predisposition to increased serum calcium, bone mineral density, and fracture risk in individuals with normal calcium levels: mendelian randomisation study. To determine if genetically increased serum calcium levels are associated with improved bone mineral density and a reduction in osteoporotic fractures.Mendelian randomisation study.Cohorts used included: the UK Biobank cohort, providing genotypic and estimated bone mineral density data; 25 cohorts from UK, USA, Europe, and China (...) , providing genotypic and fracture data; and 17 cohorts from Europe, providing genotypic and serum calcium data (summary level statistics).A genome-wide association meta-analysis of serum calcium levels in up to 61 079 individuals was used to identify genetic determinants of serum calcium levels. The UK Biobank study was used to assess the association of genetic predisposition to increased serum calcium with estimated bone mineral density derived from heel ultrasound in 426 824 individuals who had

2019 BMJ

4. Calcium, vitamin D or recombinant parathyroid hormone for managing post-thyroidectomy hypoparathyroidism. (PubMed)

Calcium, vitamin D or recombinant parathyroid hormone for managing post-thyroidectomy hypoparathyroidism. Post-surgical hypoparathyroidism is a common complication after thyroid surgery. The incidence is likely to increase given the rising trend in the annual number of thyroid operations being performed. Measures to prevent post-thyroidectomy hypoparathyroidism including different surgical techniques and prophylactic calcium and vitamin D supplements have been extensively studied (...) . The management of post-thyroidectomy hypoparathyroidism however has not been extensively evaluated. Routine use of calcium and vitamin D supplements in the postoperative period may reduce the risk of symptoms, temporary hypocalcaemia and hospital stay. However, this may lead to overtreatment and has no effect on long-term hypoparathyroidism. Current recommendations on the management of post-thyroidectomy hypoparathyroidism is based on low-quality evidence. Existing guidelines do not often distinguish between

2019 Cochrane

5. Effect of Calcium-Channel Blocker Therapy on Radial Artery Grafts After Coronary Bypass Surgery

Effect of Calcium-Channel Blocker Therapy on Radial Artery Grafts After Coronary Bypass Surgery Few studies have evaluated the effect of chronic calcium-channel blocker therapy (CCB) on the angiographic and clinical outcome of radial artery (RA) grafts used for coronary bypass surgery.The purpose of this study was to evaluate if CCB influences midterm clinical and angiographic outcomes of RA grafts.Patient-level data of 6 angiographic randomized trials evaluating RA graft status at midterm

2019 EvidenceUpdates

6. Calcium antagonists for acute ischemic stroke. (PubMed)

Calcium antagonists for acute ischemic stroke. The sudden loss of blood supply in ischemic stroke is associated with an increase of calcium ions within neurons. Inhibiting this increase could protect neurons and might reduce neurological impairment, disability, and handicap after stroke.To assess the effects of calcium antagonists for reducing the risk of death or dependency after acute ischemic stroke. We investigated the influence of different drugs, dosages, routes of administration, time (...) of VIP information, and Wanfang Data. We also searched the following trials registers: ClinicalTrials.gov, EU Clinical Trials Register, Stroke Trials Registry, ISRCTN registry, WHO International Clinical Trials Registry Platform, and Chinese Clinical Trial Registry, and we contacted trialists and researchers.Randomized controlled trials comparing a calcium antagonist versus control in people with acute ischemic stroke.Two review authors independently selected trials, extracted data, assessed risk

2019 Cochrane

7. Calcium channel blockers are useful in managing Raynaud’s phenomenon

Calcium channel blockers are useful in managing Raynaud’s phenomenon Calcium channel blockers are useful in managing Raynaud’s phenomenon Discover Portal Discover Portal Calcium channel blockers are useful in managing Raynaud’s phenomenon Published on 20 February 2018 doi: Calcium channel blockers, such as nifedipine, are confirmed as useful in reducing the frequency, duration, severity of attacks, pain and disability associated with Raynaud’s phenomenon. People had two to six fewer attacks per (...) week on average with treatment, and 13 without. Raynaud’s is a disorder which reduces blood flow to the fingers and toes as a result of the blood vessels tightening and going into spasm in the cold. This updated review suggested that calcium channel blockers may be more effective in higher doses than lower doses and help primary symptoms rather than the secondary form of Raynaud’s that is due to underlying disease. Most research has been into nifedipine. Although no serious adverse events while

2019 NIHR Dissemination Centre

8. Prepregnancy and early pregnancy calcium supplementation among women at high risk of pre-eclampsia: a multicentre, double-blind, randomised, placebo-controlled trial. (PubMed)

Prepregnancy and early pregnancy calcium supplementation among women at high risk of pre-eclampsia: a multicentre, double-blind, randomised, placebo-controlled trial. Reducing deaths from hypertensive disorders of pregnancy is a global priority. Low dietary calcium might account for the high prevalence of pre-eclampsia and eclampsia in low-income countries. Calcium supplementation in the second half of pregnancy is known to reduce the serious consequences of pre-eclampsia; however, the effect (...) of calcium supplementation during placentation is not known. We aimed to test the hypothesis that calcium supplementation before and in early pregnancy (up to 20 weeks' gestation) prevents the development of pre-eclampsia METHODS: We did a multicountry, parallel arm, double-blind, randomised, placebo-controlled trial in South Africa, Zimbabwe, and Argentina. Participants with previous pre-eclampsia and eclampsia received 500 mg calcium or placebo daily from enrolment prepregnancy until 20 weeks

2019 Lancet

9. The methodological quality of guideline recommendations on vitamin D and calcium intakes: a systematic review of food-based dietary guidelines and osteoporosis prevention guidelines

The methodological quality of guideline recommendations on vitamin D and calcium intakes: a systematic review of food-based dietary guidelines and osteoporosis prevention guidelines Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility

2019 PROSPERO

10. Randomised trials of vitamin D and calcium for the prevention of fracture in their epidemiological context

Randomised trials of vitamin D and calcium for the prevention of fracture in their epidemiological context Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2019 PROSPERO

11. Association of pre-admission calcium channel blockers use and mortality in patients with sepsis: a systematic review and meta-analysis of cohort studies

Association of pre-admission calcium channel blockers use and mortality in patients with sepsis: a systematic review and meta-analysis of cohort studies Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

12. Utility of coronary calcium scoring in connective tissue disorders for the evaluation of subclinical coronary atherosclerosis - a systematic review

Utility of coronary calcium scoring in connective tissue disorders for the evaluation of subclinical coronary atherosclerosis - a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

13. Systematic literature review on the influence of physico-chemical characteristics of calcium phosphate-based biomaterials used in preclinical bone regeneration models

Systematic literature review on the influence of physico-chemical characteristics of calcium phosphate-based biomaterials used in preclinical bone regeneration models Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability

2019 PROSPERO

14. Systematic review and meta-analysis of vitamin D/calcium and risk of ovarian cancer

Systematic review and meta-analysis of vitamin D/calcium and risk of ovarian cancer Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email

2019 PROSPERO

15. Study of biocompatibility of calcium silicate-based endodontic cements associated with different radiopacifiers: a systematic review

Study of biocompatibility of calcium silicate-based endodontic cements associated with different radiopacifiers: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record

2019 PROSPERO

16. Diagnosis and management of hyperphosphateamia in CKD: the use of calcium and non-calcium based phosphate binders to manage serum phosphate and its associated outcomes

Diagnosis and management of hyperphosphateamia in CKD: the use of calcium and non-calcium based phosphate binders to manage serum phosphate and its associated outcomes Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability

2019 PROSPERO

17. Diagnosis and management of hyperphosphateamia in CKD: the use of calcium and non-calcium based phosphate binders to manage serum phosphate and its associated outcomes

Diagnosis and management of hyperphosphateamia in CKD: the use of calcium and non-calcium based phosphate binders to manage serum phosphate and its associated outcomes Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability

2019 PROSPERO

18. Critical risk alert thresholds for total serum calcium results requiring immediate medical attention and action - a systematic review

Critical risk alert thresholds for total serum calcium results requiring immediate medical attention and action - a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record

2019 PROSPERO

19. Is calcium hydroxide effective against endotoxins in the infected canals of deciduous and permanent teeth? A systematic review

Is calcium hydroxide effective against endotoxins in the infected canals of deciduous and permanent teeth? A systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any

2019 PROSPERO

20. Clinical efficacy and safety of calcium dobesilate in the treatment of diabetic nephropathy: systematic evaluation

Clinical efficacy and safety of calcium dobesilate in the treatment of diabetic nephropathy: systematic evaluation Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated

2019 PROSPERO